Oncosoft develops AI-based medical software for radiotherapy and radiology services.
Founded in 2019 and based in Seoul, South Korea, Oncosoft provides cloud-based medical software for hospitals, using AI to support radiotherapy and radiology services for cancer diagnosis and treatment. Its tools automate image segmentation and sample contouring. In July 2026, the company raised KRW 16 billion from returning investors HB Investment and Devsisters Ventures, with participation from COMES Investment, Horizon Investment, Wanted Lab Partners, G.N.TECH Venture Capital, Timeworks Investment, and Korea Investment & Securities.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in